SUCHTUTORIUM ANZEIGENSuch-Tutorium anzeigen
(Benötigt Flash, öffnet sich in neuem Fenster) Show Tutorial VideoSuch-Tutorium anzeigen
(Benötigt Flash, öffnet sich in neuem Fenster)
Produktdetails

anti-4-HNE Antikörper

Übersicht

Bild für anti-4-HNE Antikörper
Antigen: 4-HNE
Klonalität: Monoklonal (HNEJ-2)
Applikation: Immunhistochemie (IHC), ELISA, Western Blot (WB)
Wirt: Maus
5 Publikationen vorhanden 5 Publikationen vorhanden
Menge: 20 ug (Produktvarianten)
Preis: 280,00 €   (Zzgl. Versandkosten und MWSt)
Bestellnummer: ABIN335415
Verfügbarkeit: Lieferbar innerhalb von 5 bis 7 Werktagen
Bestellhinweis Bestellhinweis
In den Warenkorb

Auf dieser Seite

Produktbeschreibung
Anwendungen
Publikationen
Bilder
Verwandte Produkte
Protokolle

Kundenservice

Technische Anfrage stellen
Produktdetails an Kollegen senden
Datenblatt herunterladen

Produktbeschreibung  » anti-4-HNE Antikörper

zurück nach oben ^


Antigen 4-HNE
Immunogen 4-Hydroxy-2-nonenal (4HNE) modified keyhole limpet hemocyanin.
Wirt Maus
Klonalität Monoklonal
Format Lyophilized
Isotyp IgG1-kappa »Passende Sekundärantikörper
Beschreibung During the peroxidation process, a variery of aldehydes are formed. 4-hydroxy-2-nonenal (4-HNE) is an alpha, beta unsatulated aldehyde that can be formed by peroxidation of omega-6 unsatulated fatty acids such as linoleic acid and arachidonic acid. Especially, 4-HNE formed inside living body is reported to originate from phospholipid-bound arachidonic acid. 4-HNE may be one of the most reliable biomarker of lipid peroxidation. This antibody shows almost negligible reactivity with proteins that were treated with other aldehydes, such as 2-nonenal, 2-hexenal, 1-hexanal, 4-hydroxy-2-hexenal,formaldehyde, or glutaraldehyde.
Klon HNEJ-2
Spezifität Specific for 4HNE-Lysine adduct in all species. This antibody has almost negligible reactivity with proteins that were treated with other aldehydes, such as 2-nonenal, 2-hexenal, 1-hexanal, 4-hydroxy-2-hexenal, formaldehyde, or glutaraldehyde. By inhibition test, this antibody shows a much higher affinity for the 4-HNE-histidine adduct than 4-HNE-lysine or 4-HNE-cysteine adduct.

Anwendungen  » anti-4-HNE Antikörper

zurück nach oben ^


Applikation Immunhistochemie (IHC), ELISA, Western Blot (WB)
» Hier finden Sie 4 Protokolle zu den gelisteten Anwendungen
Applikationshinweise IHC, Western and/or ELISA. Immunohistochemistry [ref.1] (Recommended concentration: 25 ug/mL IgG). Western blotting [ref.2] (Recommended concentration: 15 ug/mL IgG) User should determine optimum titer for each application.
Reinigung Ammonium sulphate purified IgG
Buffer Lyophilized as 100 ug/mL IgG in 50mM Tris buffered saline (TBS)
Lagerung Less than -20°C, stable for 5 years Recinstitute with 200µl of distilled water.
Forschungsgebiet Neurologie
Beschränkungen Nur für Forschungszwecke einsetzbar

Publikationen  » anti-4-HNE Antikörper

zurück nach oben ^


Publikationen Toyokuni, Miyake, Hiai et al.: "The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct." In: FEBS letters, Vol. 359, Issue 2-3, pp. 189-91, 1995 (PubMed)

Tanaka, Nishiyama, Okada et al.: "Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion." In: Laboratory investigation; a journal of technical methods and pathology, Vol. 77, Issue 2, pp. 145-55, 1997 (PubMed)

Nakajima, Inokuchi, Shimazawa et al.: "Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo." In: The Journal of pharmacy and pharmacology, Vol. 60, Issue 10, pp. 1365-74, 2008 (PubMed)

Sedlak, Saleh, Higginson et al.: "Bilirubin and glutathione have complementary antioxidant and cytoprotective roles." In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, Issue 13, pp. 5171-6, 2009 (PubMed)

Boretti, Buehler, DAgnillo et al.: "Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs." In: The Journal of clinical investigation, Vol. 119, Issue 8, pp. 2271-80, 2009 (PubMed)